Koichiro Asano Selected Research

BW 245C

3/2005

Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koichiro Asano Research Topics

Disease

38	Asthma (Bronchial Asthma) 01/2022 - 10/2002
22	Inflammation (Inflammations) 01/2021 - 02/2002
11	Neoplasms (Cancer) 07/2022 - 09/2009
11	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 01/2015
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 11/2003
6	Pneumonia (Pneumonitis) 07/2022 - 01/2010
6	Lung Neoplasms (Lung Cancer) 07/2022 - 09/2009
6	Allergic Bronchopulmonary Aspergillosis 01/2021 - 01/2018
6	Emphysema 07/2018 - 08/2012
5	Infections 06/2021 - 04/2014
5	Eosinophilia 09/2018 - 03/2005
4	Pleural Effusion (Pleural Effusions) 02/2021 - 09/2015
3	Pulmonary Hypertension 04/2022 - 10/2013
3	Pulmonary Arterial Hypertension 01/2021 - 10/2013
3	Eczema 12/2020 - 03/2011
3	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2020 - 05/2012
3	Adenocarcinoma of Lung 09/2020 - 09/2009
3	Lung Injury 01/2018 - 03/2008
3	Acute Lung Injury 03/2010 - 03/2008
2	Disease Progression 09/2022 - 03/2012
2	Respiratory Insufficiency (Respiratory Failure) 09/2022 - 10/2020
2	Organizing Pneumonia 05/2022 - 04/2022
2	Cough 05/2022 - 09/2014
2	Hypoxia (Hypoxemia) 04/2022 - 06/2009
2	COVID-19 04/2022 - 09/2021
2	Allergic Rhinitis 01/2022 - 03/2005
2	Empyema 06/2021 - 01/2017
2	Idiopathic Pulmonary Fibrosis 02/2021 - 03/2010
2	Anaphylaxis (Anaphylactic Shock) 01/2021 - 01/2021
2	Hypersensitivity (Allergy) 01/2021 - 01/2021
2	Rhinosinusitis 10/2020 - 04/2015
2	Fibrosis (Cirrhosis) 01/2019 - 11/2012
2	Obstructive Sleep Apnea 01/2017 - 07/2016
2	Osteoporosis 02/2015 - 08/2012
2	Respiratory Hypersensitivity 05/2014 - 12/2004
2	Sepsis (Septicemia) 04/2014 - 06/2012
2	Carcinoma (Carcinomatosis) 03/2012 - 03/2010
1	Pleurisy (Pleuritis) 09/2022
1	Rhabdomyolysis 05/2022
1	Paralysis (Palsy) 04/2022
1	Pericardial Effusion 04/2022
1	Fever (Fevers) 04/2022
1	Neutropenia 04/2022
1	Hypotension (Low Blood Pressure) 04/2022

Drug/Important Bio-Agent (IBA)

14	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022 - 10/2002
8	Biomarkers (Surrogate Marker)IBA 04/2020 - 08/2012
7	ProstaglandinsIBA 01/2011 - 02/2002
6	Immunoglobulin E (IgE)IBA 01/2022 - 01/2018
6	AntibodiesIBA 01/2022 - 01/2015
6	CytokinesIBA 12/2020 - 11/2012
5	Anti-Bacterial Agents (Antibiotics)IBA 07/2022 - 04/2014
5	AllergensIBA 01/2022 - 01/2008
5	Prostaglandins DIBA 11/2012 - 03/2005
4	Immunoglobulin G (IgG)IBA 01/2021 - 05/2014
3	Oxygen (Dioxygen)IBA 09/2022 - 08/2012
3	ErbB Receptors (EGF Receptor)IBA 05/2022 - 07/2011
3	COVID-19 VaccinesIBA 05/2022 - 01/2021
3	Carboplatin (JM8)FDA LinkGeneric 04/2022 - 11/2003
3	PeriostinIBA 01/2021 - 04/2015
3	AntigensIBA 01/2018 - 07/2013
3	Interleukin-33IBA 01/2017 - 01/2013
3	Interleukin-13IBA 03/2016 - 11/2012
3	InterleukinsIBA 09/2015 - 05/2014
3	Pharmaceutical PreparationsIBA 06/2015 - 09/2009
3	Methacholine Chloride (Methacholine)FDA Link 05/2014 - 01/2008
3	AcidsIBA 01/2010 - 03/2005
2	Tyrosine Kinase InhibitorsIBA 05/2022 - 09/2020
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2022 - 09/2009
2	Immune Checkpoint InhibitorsIBA 04/2022 - 11/2019
2	16S Ribosomal RNAIBA 06/2021 - 01/2017
2	Prednisolone (Predate)FDA LinkGeneric 02/2021 - 01/2015
2	Omalizumab (Xolair)FDA Link 10/2020 - 01/2020
2	mepolizumabIBA 10/2020 - 09/2019
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020 - 04/2015
2	prostaglandin D2 receptorIBA 01/2019 - 01/2011
2	Volatile Organic CompoundsIBA 01/2017 - 01/2017
2	Interleukin-5 (Interleukin 5)IBA 03/2016 - 03/2005
2	Interleukin-23 (Interleukin 23)IBA 09/2015 - 05/2014
2	LipocalinsIBA 11/2012 - 06/2009
2	Docetaxel (Taxotere)FDA Link 09/2009 - 11/2003
2	pranlukastIBA 08/2009 - 10/2002
2	Prostaglandin D2IBA 06/2009 - 01/2008
2	Thromboxane Receptors (Thromboxane Receptor)IBA 12/2008 - 03/2005
2	Prostaglandin H2 Thromboxane A2 ReceptorsIBA 01/2008 - 12/2004
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2008 - 02/2002
1	Gefitinib (Iressa)FDA Link 05/2022
1	BNT162 VaccineIBA 05/2022
1	Peroxidase (Myeloperoxidase)IBA 04/2022
1	tepotinibIBA 04/2022
1	pembrolizumabIBA 04/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2022

Therapy/Procedure

13	Therapeutics 09/2022 - 08/2006
4	Drug Therapy (Chemotherapy) 09/2014 - 09/2009
2	Aftercare (After-Treatment) 04/2022 - 05/2012
2	Chemoradiotherapy 09/2020 - 01/2015
2	Combination Drug Therapy (Combination Chemotherapy) 09/2009 - 11/2003
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 09/2022
1	Antibiotic Prophylaxis 07/2022